Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Centrient Pharmaceuticals logo — Global B2B leader in sustainable, enzymatic antibiotics, nex...

Centrient Pharmaceuticals

Global B2B leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals

Founded 1869 The Netherlands The Netherlands 926 employees

General Information

Company Name Centrient Pharmaceuticals
Founded Year 1869
Location The Netherlands The Netherlands +13
Employees 926
Social

Get notified when Centrient Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Centrient Pharmaceuticals

Centrient Pharmaceuticals is a global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins, and anti-fungals. The company produces and sells intermediates and active pharmaceutical ingredients (APIs), as well as its own tablets, capsules, and other finished dosage forms (FDFs). With a history dating back to 1869 as the ‘Nederlandsche Gist- en Spiritusfabriek’, the company has evolved through various names including Gist Brocades and DSM Sinochem Pharmaceuticals, and is currently headquartered in The Netherlands, with production facilities and sales offices across China, India, Spain, the United States, and Mexico. Centrient Pharmaceuticals, with over 1,800 employees, prides itself on its commitment to Quality, Reliability, and Sustainability at the core of its operations. Notably, the company actively participates in the fight against antimicrobial resistance, positioning itself at the center of modern healthcare as a maker of essential and life-saving medicines. Centrient Pharmaceuticals is Bain Capital Private Equity's portfolio company, a leading global private investment firm, which injects significant resources and expertise into the company’s growth and development. As a global market leader in its niche, Centrient Pharmaceuticals is well-positioned to capitalize on the increasing demand for sustainable pharmaceuticals. The company’s focus on sustainability and its extensive product portfolio make it an attractive investment opportunity for venture capitalists seeking to support innovative solutions in the pharmaceutical industry.

Taxonomy: Pharmaceuticals, APIs, Antibiotics, Statins, Anti-fungals, Reliability, Sustainable Future, Antimicrobial Resistance, Global Leader, Enzymatic, Investment

No funding data available for Centrient Pharmaceuticals yet.

Get notified when Centrient Pharmaceuticals raises funding

Centrient Pharmaceuticals Alternatives & Competitors

Centrient Pharmaceuticals vs
Global Innovation through Science and Technology
Global Innovation through Science and Technology

We connect you through resources, solutions and support.

7 employees
Centrient Pharmaceuticals vs
GIST Impact
GIST Impact Switzerland

We deliver impact intelligence

Series Unknown
189 employees
Analytics, Data Analytics
Centrient Pharmaceuticals vs
Gist Labs
Gist Labs United States

Gist Labs is a technology and management consulting company established on an Agile/Lean foundation....

1 employees
Information Technology, CRM and Sales

FAQ About Centrient Pharmaceuticals

Global B2B leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals
Centrient Pharmaceuticals was founded in 1869.
Centrient Pharmaceuticals is headquartered in The Netherlands.
Centrient Pharmaceuticals has approximately 926 employees.
Top alternatives and competitors to Centrient Pharmaceuticals include Global Innovation through Science and Technology, GIST Impact, Gist Labs, Kepro Holland, MUXIMA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Centrient Pharmaceuticals and Global Innovation through Science and Technology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Centrient Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy